Matches in Nanopublications for { ?s ?p "[The efficacy of LPZ (15 mg/day) as maintenance therapy for erosive RE is influenced by CYP2C19 polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_assertion description "[The efficacy of LPZ (15 mg/day) as maintenance therapy for erosive RE is influenced by CYP2C19 polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP45828.RAIyLy-dXBM9Za5Q0WGPi7qAEa7DPTEXCHdPwNMunosmc130_provenance.
- NP406553.RAc2iq0clFMRzQlCcWsmz6wQxTcGhemFi0doV9nACv4W8130_assertion description "[The efficacy of LPZ (15 mg/day) as maintenance therapy for erosive RE is influenced by CYP2C19 polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406553.RAc2iq0clFMRzQlCcWsmz6wQxTcGhemFi0doV9nACv4W8130_provenance.
- NP55113.RAVvbakre5DYTK7A1XasKXaafEN8nJW3j_Dy5C0LPwwSA130_assertion description "[The efficacy of LPZ (15 mg/day) as maintenance therapy for erosive RE is influenced by CYP2C19 polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55113.RAVvbakre5DYTK7A1XasKXaafEN8nJW3j_Dy5C0LPwwSA130_provenance.
- assertion description "[The efficacy of LPZ (15 mg/day) as maintenance therapy for erosive RE is influenced by CYP2C19 polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP105462.RA8etyWXzwzMFOgsZ1Uf4S_2hSAclCye_bHYIS1tP3eRI130_assertion description "[The efficacy of LPZ (15 mg/day) as maintenance therapy for erosive RE is influenced by CYP2C19 polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105462.RA8etyWXzwzMFOgsZ1Uf4S_2hSAclCye_bHYIS1tP3eRI130_provenance.